NextCure Inc (NXTC)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE, MD 20705

NextCure, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on discovering and developing next generation immunomedicines for cancer and other diseases. NextCure serves health care industry.

View SEC Filings from NXTC instead.

View recent insider trading info

Funds Holding NXTC (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding NXTC BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

NICHOLSON GARRY A

  • Director
0 2020-03-25 1

MORRISON BRIGGS

  • Director
29,520 2020-03-24 2

SHANNON TIMOTHY M

  • Director
4,551,177 2020-03-20 3

ALEXANDRIA VENTURE INVESTMENTS, LLC

  • 10% Owner
293,013 2020-03-16 2

KHUONG CHAU QUANG

  • Director
348,473 2020-03-06 3

ORBIMED ADVISORS LLC

ORBIMED CAPITAL GP VI LLC

  • 10% Owner
9,520,000 2020-03-06 1

MAYER TIMOTHY CHIEF OPERATING OFFICER

  • Officer
0 2020-02-28 2

LANGERMANN SOL CHIEF SCIENTIFIC OFFICER

  • Officer
0 2020-02-28 2

LIU LINDA SVP, RESEARCH

  • Officer
0 2020-02-28 3

HELLER KEVIN N. CHIEF MEDICAL OFFICER

  • Officer
0 2020-02-28 2

COBOURN STEVEN P. CHIEF FINANCIAL OFFICER

  • Officer
0 2020-02-28 2

BINGHAM JAMES B. CHIEF DEVELOPMENT OFFICER

  • Officer
0 2020-02-28 2

RICHMAN MICHAEL PRESIDENT & CEO

  • Officer
  • Director
0 2020-02-28 2

KABAKOFF DAVID S

  • Director
  • 10% Owner
1,683,577 2020-02-19 2

CANAAN X L.P.

CANAAN PARTNERS X LLC

  • Director
  • 10% Owner
0 2020-01-21 2

WEBSTER STEPHEN W

  • Director
0 2020-01-02 2

SOFINNOVA VENTURE PARTNERS IX, L.P.

SOFINNOVA MANAGEMENT IX, L.L.C.

HEALY JAMES

MEHRA ANAND

POWELL MICHAEL

  • 10% Owner
2,671,856 2019-11-15 1

JONES ELAINE V

  • Director
0 2019-09-12 2

LI JUDITH

  • Director
0 2019-06-19 2

XU STELLA

  • Director
0 2019-06-13 2

XU STELLA

QUAN VENTURE FUND II, L.P.

  • Director
  • 10% Owner
0 2019-05-08 1

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

COBOURN STEVEN P. - Officer CHIEF FINANCIAL OFFICER

2020-02-28 A 78,200 a 78,200 0.00 direct

LANGERMANN SOL - Officer CHIEF SCIENTIFIC OFFICER

2020-02-28 A 78,200 a 78,200 0.00 direct

LIU LINDA - Officer SVP, RESEARCH

2020-02-28 A 39,100 a 39,100 0.00 direct

RICHMAN MICHAEL - Director - Officer PRESIDENT & CEO

2020-02-28 A 225,000 a 225,000 0.00 direct

HELLER KEVIN N. - Officer CHIEF MEDICAL OFFICER

2020-02-28 A 100,050 a 100,050 0.00 direct

BINGHAM JAMES B. - Officer CHIEF DEVELOPMENT OFFICER

2020-02-28 A 78,200 a 78,200 0.00 direct

MAYER TIMOTHY - Officer CHIEF OPERATING OFFICER

2020-02-28 A 78,200 a 78,200 0.00 direct

Elevate your investments